MedPath

PG2

Generic Name
PG2
Clinical Trials
Related News

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

Phase 2
Withdrawn
Conditions
Surgery
Fatigue
Cancer
Interventions
Drug: Placebo
First Posted Date
2014-03-04
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Registration Number
NCT02077621
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy

Phase 1
Completed
Conditions
Neoplasm Metastasis
Neoplasm Recurrence
Interventions
First Posted Date
2012-10-01
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Target Recruit Count
32
Registration Number
NCT01696565
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

PG2 Injection 500 mg in Acute Stroke Study (Pass)

Phase 2
Completed
Conditions
Acute Stroke
Interventions
Drug: placebo
First Posted Date
2012-05-22
Last Posted Date
2016-11-04
Lead Sponsor
China Medical University Hospital
Target Recruit Count
86
Registration Number
NCT01603667
Locations
🇨🇳

China Medical University Hospital, Taichung, Taiwan

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Early Phase 1
Completed
Conditions
Hemorrhagic Stroke
Interventions
Drug: Placebo
First Posted Date
2011-03-29
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Target Recruit Count
61
Registration Number
NCT01325233
Locations
🇨🇳

China Medical University Hospital, Taichung, Taiwan

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Phase 2
Completed
Conditions
Idiopathic Thrombocytopenic Purpura (ITP)
Interventions
First Posted Date
2009-03-12
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Target Recruit Count
14
Registration Number
NCT00860600
Locations
🇨🇳

Changhua Christian Hospital, Changhua, Taiwan

🇨🇳

Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

🇨🇳

National Cheng Kung University Hospital, Tainan, Taiwan

and more 1 locations

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Phase 2
Completed
Conditions
Fatigue
Interventions
Drug: Placebo
First Posted Date
2007-08-30
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Target Recruit Count
91
Registration Number
NCT00523107
Locations
🇨🇳

Mackay Memorial Hospital, New Taipei City, Taiwan

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Phase 2
Terminated
Conditions
Fatigue
Complementary
Quality of Life
Interventions
First Posted Date
2007-08-21
Last Posted Date
2024-11-06
Lead Sponsor
PhytoHealth Corporation
Target Recruit Count
13
Registration Number
NCT00518869
Locations
🇨🇳

National Cheng-Kung University Hospital, Tainan, Taiwan

🇨🇳

Chang-Gung Memorial Hospital - Kaoshiung, Kaohsiung, Taiwan

🇨🇳

China Medical University Hospital, Taichung, Taiwan

and more 7 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy